APA (7th ed.) Citation

R, F., ME, C., HH, D., & JL, V. (2019). Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: Integrated analysis of two Phase III clinical studies. Dove Medical Press.

Chicago Style (17th ed.) Citation

R, Fong, Cavet ME, DeCory HH, and Vittitow JL. Loteprednol Etabonate (submicron) Ophthalmic Gel 0.38% Dosed Three Times Daily Following Cataract Surgery: Integrated Analysis of Two Phase III Clinical Studies. Dove Medical Press, 2019.

MLA (8th ed.) Citation

R, Fong, et al. Loteprednol Etabonate (submicron) Ophthalmic Gel 0.38% Dosed Three Times Daily Following Cataract Surgery: Integrated Analysis of Two Phase III Clinical Studies. Dove Medical Press, 2019.